Showing results (221-230 of 263) with videos related to

Sort By:
Pageof 27
Cancer Research|June 15, 1989
Immunotoxin-mediated inhibition of chronic lymphocytic leukemia cell proliferation in humansS Siena, M Bregni, A Formosa, et al.
Journal of the National Cancer Institute|June 1, 1988
Activity of a monoclonal antibody-saporin-6 conjugate against B-lymphoma cellsM Bregni, D A Lappi, S Siena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1995
Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humansL Gianni, C M Kearns, A Giani, et al.
Breast Cancer Research and Treatment|January 1, 1996
Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II studyM Terenziani, R Demicheli, C Brambilla, et al.
The New England Journal of Medicine|October 8, 1981
Quality of institutional participation in multicenter clinical trialsR J Sylvester, H M Pinedo, M De Pauw, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1987
Increased basal and thrombin-induced free calcium in platelets of essential hypertensive patientsA Lechi, C Lechi, G Bonadonna, et al.
Bone Marrow Transplantation|August 1, 1990
Durable and complete hematopoietic reconstitution after autografting of rhGM-CSF exposed peripheral blood progenitor cellsA M Gianni, C Tarella, S Siena, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 1997
Initial chemotherapy for primary resectable large-cell lymphoma of the stomachC Tondini, M Balzarotti, A Santoro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphomaA Fosså, A Santoro, W Hiddemann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1992
Granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor infusion makes high-dose etoposide a safe outpatient regimen that is effective in lymphoma and myeloma patientsA M Gianni, M Bregni, S Siena, et al.
Pageof 27